Cite
Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features
MLA
Hesong Zou, et al. “Favorable Outcomes of Front-Line Risk-Adapted Therapy in Young Patients with Diffuse Large B-Cell Lymphoma with Clinically or Biologically High-Risk Features.” Chinese Medical Journal, vol. 137, no. 13, July 2024, pp. 1620–22. EBSCOhost, https://doi.org/10.1097/CM9.0000000000002940.
APA
Hesong Zou, Wei Liu, Yi Wang, Dandan Shan, Ting Xie, Ru Li, Huimin Liu, Wenyang Huang, Mingwei Fu, Tingyu Wang, Rui Lyu, Shuhui Deng, Weiwei Sui, Yan Xu, Shuhua Yi, Gang An, Lugui Qiu, Dehui Zou, Ting Gao, & Xiuyuan Hao. (2024). Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features. Chinese Medical Journal, 137(13), 1620–1622. https://doi.org/10.1097/CM9.0000000000002940
Chicago
Hesong Zou, Wei Liu, Yi Wang, Dandan Shan, Ting Xie, Ru Li, Huimin Liu, et al. 2024. “Favorable Outcomes of Front-Line Risk-Adapted Therapy in Young Patients with Diffuse Large B-Cell Lymphoma with Clinically or Biologically High-Risk Features.” Chinese Medical Journal 137 (13): 1620–22. doi:10.1097/CM9.0000000000002940.